/
/
/

Onesource Specialty Pharma Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
₹449 Cr₹428 Cr₹290 Cr₹376 Cr₹327 Cr₹426 Cr₹393 Cr₹334 Cr₹292 Cr₹73 Cr₹56 Cr₹34 Cr
₹4 Cr₹2 Cr₹5 Cr₹3 Cr₹5 Cr₹3 Cr₹7 Cr₹4 Cr₹4 Cr₹3 Cr₹1 Cr₹9 L
₹453 Cr₹430 Cr₹295 Cr₹379 Cr₹333 Cr₹429 Cr₹399 Cr₹338 Cr₹296 Cr₹76 Cr₹57 Cr₹34 Cr
₹397 Cr₹408 Cr₹343 Cr₹339 Cr₹307 Cr₹312 Cr₹319 Cr₹325 Cr₹296 Cr₹95 Cr₹86 Cr₹91 Cr
₹127 Cr₹94 Cr₹22 Cr₹110 Cr₹94 Cr₹185 Cr₹149 Cr₹82 Cr₹68 Cr-₹16 L-₹9 Cr-₹38 Cr
₹31 Cr₹23 Cr₹38 Cr₹34 Cr₹27 Cr₹33 Cr₹46 Cr₹45 Cr₹42 Cr₹20 Cr₹26 Cr₹25 Cr
₹20 Cr-₹29 L-₹93 Cr₹6 Cr-₹4 Cr₹84 Cr-₹67 Cr-₹37 Cr-₹47 Cr-₹40 Cr-₹161 Cr-₹87 Cr
₹25 Cr₹5 Cr-₹89 Cr₹10 Cr-₹19 L₹99 Cr-₹69 Cr-₹42 Cr-₹6 Cr-₹40 Cr-₹130 Cr-₹114 Cr

Share Price Live Stats

Open (₹)1,459.10
Volume (₹)3.03 L
High (₹)1,460.00
Upper Circuit1,750.90
Low (₹)1,423.90
Lower Circuit1,167.30
Prev Close1,459.10
52W High (₹)1,925.00
Price1,442.40
52W Low (₹)1,057.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)16753.80 Cr
Div. Yield (%)0.00
PE Ratio0.00
Debt to Equity0.22
Price to Book2.90
Book Value508.17
EPS (TTM)-4.24
Face Value1.00
ROE (%)-1.26

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
LAURUSLABSNSE
CIPLANSE
DRREDDYNSE
MANKINDNSE
AUROPHARMANSE
LUPINNSE
ONESOURCENSE
LTP
1W Low
1W High
Market cap (₹)
1746.4-13.6 (-0.77%)
1725.50
1776.60
4,24,466Cr
9023-317 (-3.39%)
8937.50
9431.50
2,46,222Cr
4580-76.9 (-1.65%)
4551.80
4682
1,76,301Cr
1124.7+7.2 (0.64%)
1107.30
1150.90
1,12,818Cr
2036.9+0.3 (0.01%)
2007.80
2069.20
1,10,823Cr
1314.6+13.6 (1.05%)
1300.20
1333.30
1,07,447Cr
1216+19 (1.59%)
1196.90
1250.70
1,03,471Cr
2335-33.5 (-1.41%)
2317.50
2426.80
97,850Cr
1662.9-30.1 (-1.78%)
1654.10
1715
96,836Cr
1953.2-3.3 (-0.17%)
1925.70
1964.90
89,629Cr
1442.4-18.9 (-1.29%)
1423.90
1503.90
16,754Cr

Key Highlights of Onesource Specialty Pharma Ltd’s P&L

In 2026-03-31, Onesource Specialty Pharma Ltd reported total revenue of ₹1468.05Cr, compared with ₹1465.04Cr in 2025-03-31, reflecting Onesource Specialty Pharma Ltd turnover.

Depreciation was ₹279.09Cr and finance costs were ₹122.19Cr in 2026-03-31

Profit Before Tax (PBT) has been ₹-₹91.96Cr in 2026-03-31 as compared to ₹-₹67.07Cr in 2025-03-31.

Net Profit (PAT) was ₹-₹73.8Cr in 2026-03-31 compared with ₹-₹17.97Cr in 2025-03-31.

Earnings per share (EPS) were ₹-6.44 in 2026-03-31, compared with ₹-1.57 in 2025-03-31.